肾去神经支配市场规模、份额、成长分析、按产品、按技术、按最终用户、按地区 - 行业预测，2025-2032 年

2023年全球去肾神经术市场规模为43364万美元，从2024年的61013万美元增长到2032年的937079万美元，复合年增长率预计将保持在40.7%。

由于高血压盛行率不断上升，以及人们越来越意识到去肾神经术作为微创治疗的好处，全球去肾神经术市场正在强劲成长。这种治疗方法可以有效阻断肾臟神经来调节血压，对患者和医疗保健提供者很有吸引力，因为它有可能减少药物依赖性并改善患者的治疗结果。技术进步，例如利用射频和超音波能量的创新导管系统，正在提高手术的准确性和安全性，并进一步促进采用。然而，挑战仍然存在，包括需要长期临床资料来检验疗效以及保险报销的障碍。儘管存在这些障碍，去肾神经市场预计将继续扩大，随着对有效高血压治疗的需求不断增长，为医疗设备创新者提供了充满希望的机会。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 案例研究
• 技术进步

肾去神经术市场规模：依产品及复合年增长率（2025-2032）

• 市场概况
• 简单
• 基础知识（V2）
• 开导
• 天堂
• 伊贝里斯
• 其他的

肾去神经术市场规模：依技术及复合年增长率（2025-2032）

• 市场概况
• 无线电频率
• 超音波
• 微量输液
• 其他的

肾去神经术市场规模：依最终用户和复合年增长率（2025-2032）

• 市场概况
• 医院
• 诊所
• 门诊手术中心
• 其他的

肾去神经术市场规模：按地区和复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Medtronic（Ireland）
• Symap Medical（China）
• Shanghai Golden Leaf Medtec（China）
• Shanghai Wisegain Medical Devices（China）
• Terumo Corporation（Japan）
• Abbott Laboratories（USA）
• Johnson & Johnson（USA）
• Boston Scientific（USA）
• St. Jude Medical（USA）
• Cordis Corporation（USA）
• Vessix Vascular（USA）
• Ardian（USA）
• Otsuka Holdings（Japan）

结论和建议

Global Renal Denervation Market size was valued at USD 433.64 million in 2023 and is poised to grow from USD 610.13 million in 2024 to USD 9370.79 million by 2032, growing at a CAGR of 40.7% during the forecast period (2025-2032).

The global renal denervation market is experiencing robust growth, driven by the rising prevalence of hypertension and increasing awareness of renal denervation's benefits as a minimally invasive treatment. This procedure effectively disrupts renal nerves to regulate blood pressure, appealing to patients and healthcare providers alike due to its potential to reduce dependence on medications and enhance patient outcomes. Technological advancements, including innovative catheter systems utilizing radiofrequency or ultrasound energy, have improved the procedure's precision and safety, further promoting adoption. However, challenges remain, such as the need for more long-term clinical data to validate efficacy and reimbursement barriers. Despite these obstacles, the renal denervation market is poised for continued expansion, offering lucrative opportunities for medical device innovators as demand for effective hypertension treatments grows.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Renal Denervation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Renal Denervation Market Segmental Analysis

Global Renal Denervation Market is segmented by product, technology, end-users and region. Based on product, the market is segmented into simplicity, vessix (V2), enlightn, paradise, iberis and others. Based on technology, the market is segmented into radiofrequency, ultrasound, micro-infusion and others. Based on end-users, the market is segmented into hospital, clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Renal Denervation Market

The Global Renal Denervation market is significantly propelled by technological advancements that enhance the effectiveness and safety of the procedure. Innovations in catheter designs, enhanced energy delivery systems, and the development of novel nerve-modifying agents are all contributing to this growth. These improvements not only increase the precision of renal denervation but also expand its clinical applications, leading to better patient outcomes. As these technologies continue to evolve, they are making renal denervation a more viable treatment option for patients with resistant hypertension, ultimately driving greater adoption and expansion of this market on a global scale.

Restraints in the Global Renal Denervation Market

The Global Renal Denervation market faces several restraints, particularly due to limited awareness and adoption in emerging markets. In these regions, the understanding of renal denervation as a viable treatment for hypertension is often minimal, which hinders its acceptance among both healthcare providers and patients. Furthermore, inadequate healthcare infrastructure exacerbates this issue, restricting access to advanced medical treatments and technologies. As a result, the growth potential of the renal denervation market in these areas is significantly constrained, as efforts to educate stakeholders and improve healthcare services are still underway. These challenges must be addressed to facilitate market expansion.

Market Trends of the Global Renal Denervation Market

The Global Renal Denervation market is witnessing a significant shift towards ambulatory settings, where procedures are increasingly performed on an outpatient basis rather than in traditional hospital environments. This trend is propelled by the dual benefits of cost-effectiveness and patient convenience, as outpatient procedures reduce hospitalization times and associated costs. Enhanced accessibility to renal denervation techniques in ambulatory settings not only democratizes patient care but also stimulates market growth by attracting a broader patient demographic seeking less invasive treatment options. As healthcare systems evolve and prioritize outpatient care, this trend is poised to reshape the landscape of renal denervation therapies globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Renal Denervation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Simplicity
• Vessix (V2)
• Enlightn
• Paradise
• Iberis
• Others

Global Renal Denervation Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Radiofrequency
• Ultrasound
• Micro-Infusion
• Others

Global Renal Denervation Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Hospital
• Clinics
• Ambulatory Surgery Centers
• Others

Global Renal Denervation Market Size & CAGR (2025-2032)

• North America (Product, Technology, End-Users)
  • US
  • Canada
• Europe (Product, Technology, End-Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, End-Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, End-Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, End-Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Symap Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Golden Leaf Medtec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Wisegain Medical Devices (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vessix Vascular (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ardian (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations